Axxcess Wealth Management LLC Makes New Investment in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE)

Axxcess Wealth Management LLC acquired a new stake in shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 5,342 shares of the company’s stock, valued at approximately $352,000. Axxcess Wealth Management LLC owned about 0.13% of Invesco Biotechnology & Genome ETF as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also made changes to their positions in the stock. Creative Financial Designs Inc. ADV lifted its position in shares of Invesco Biotechnology & Genome ETF by 6.6% during the 4th quarter. Creative Financial Designs Inc. ADV now owns 3,347 shares of the company’s stock worth $220,000 after purchasing an additional 206 shares during the last quarter. Kestra Advisory Services LLC grew its stake in shares of Invesco Biotechnology & Genome ETF by 4.2% in the third quarter. Kestra Advisory Services LLC now owns 6,362 shares of the company’s stock worth $363,000 after acquiring an additional 254 shares during the last quarter. YHB Investment Advisors Inc. increased its position in Invesco Biotechnology & Genome ETF by 0.9% during the fourth quarter. YHB Investment Advisors Inc. now owns 22,755 shares of the company’s stock worth $1,498,000 after acquiring an additional 200 shares during the period. Global Retirement Partners LLC acquired a new position in Invesco Biotechnology & Genome ETF during the 4th quarter valued at $39,000. Finally, Stratos Wealth Partners LTD. bought a new stake in Invesco Biotechnology & Genome ETF in the 4th quarter valued at $208,000.

Invesco Biotechnology & Genome ETF Price Performance

Shares of PBE stock opened at $63.75 on Thursday. Invesco Biotechnology & Genome ETF has a one year low of $52.47 and a one year high of $67.76. The stock has a market cap of $241.61 million, a P/E ratio of 16.00 and a beta of 0.92. The stock has a fifty day moving average price of $63.57 and a 200 day moving average price of $62.26.

Invesco Biotechnology & Genome ETF Profile

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies.